older adults

50 all articles · 20 / page

Ask MedXY AI

Latest news

Tag

All articles

Can Prehabilitation Reduce Complications After Spinal Fusion in Older Adults? What a New Randomized Trial Suggests

A multicenter randomized trial found that 4-week multimodal prehabilitation added to ERAS reduced 90-day complications after spinal fusion in adults aged 75 years or older.

Section: newsJun 20, 2026

Allogeneic Stem Cell Transplantation After 70: Japanese Registry Data Define Who May Benefit Most

A Japanese registry study of 929 patients aged 70+ identified six predictors of worse survival after allo-HSCT and created a simple score that sharply stratified 2-year overall survival from 57.1% to 2.5%.

older adults

Latest news

Can Prehabilitation Reduce Complications After Spinal Fusion in Older Adults? What a New Randomized Trial Suggests

Allogeneic Stem Cell Transplantation After 70: Japanese Registry Data Define Who May Benefit Most

Low-Level Airborne Particulate Matter and Risk of Hypertension Hospitalization in Older U.S. Adults

Low-Level Airborne Particulate Matter and Risk of Hypertension Hospitalization in Older U.S. Adults

One in Six Older Emergency Department Patients Has Delirium: New Multisite Data Highlight Missed Risk, Mixed Management, and Higher Hospital Use

One in Six Older Adults Presenting to the Emergency Department Had Delirium, With Higher Admission and 30-Day Readmission Risk

A Clinically Relevant Threshold of Impaired Contrast Sensitivity Among Older US Adults

Cerebral “Dirty-Appearing” White Matter and Its Link to Cognitive Decline and Dementia Risk

Rates of Systemic Treatment for Metastatic Non-Small Cell Lung Cancer Among Older Adults

Systemic Treatment Remains Underused in Older Adults With Metastatic Non-Small Cell Lung Cancer

Coronary Revascularization in Older Adults: Key Recommendations from the 2025 AHA Scientific Statement

Stepping Down Antihypertensives in Frail Nursing-Home Residents Did Not Reduce Mortality: Results from the RETREAT-FRAIL Trial

Geographic Clusters of Late-Life Epilepsy in US Medicare: Sleep and Mobility as Key Contextual Drivers

Bivalent RSV pre‑F Vaccine Dramatically Reduces RSV‑Associated Hospitalisations and Chronic‑Disease Exacerbations in Adults Aged 75–79 Years

Brand-Specific Influenza Vaccine Effectiveness in Nordic Older Adults: Insights from the 2024-2025 Season Registry-Based Target Trial Emulation

DAGO2 (daunorubicin+cytarabine+fractionated gemtuzumab) outperforms CPX‑351 in older adults with non‑adverse‑risk AML: insights from NCRI AML18

RSV prefusion F bivalent vaccine protects older adults similarly whether or not they have atherosclerotic cardiovascular disease

High‑Dose Influenza Vaccine Reduces Hospitalisations in Older Adults

Each Hour Sitting Counts: Sedentary Time Linked to Lower Intrinsic Capacity and Faster Decline in Older Adults

Fast versus Slow Compression in Hearing Aids: Hearing Thresholds Predict Preference but Not Speech Outcomes